I-O SUMMIT 2018 - ONCOLOGIA

Practical issues 2: Response Patterns 

Dr. Jose Zarbá

Clinical Case 1: Metastatic Melanoma – Monotherapy 

Dr. Iván Márquez

New approaches in special populations in Metastatic Melanoma 

Dra. Gabriela Cinat

Navigating treatment decisions in Metastastatic Melanoma: Key considerations in treatment decision

Dra. Gabriela Cinat

Discussion about 1st line choice in Metastatic Melanoma: Immunotherapy vs Targeted Therapy

Dr. Iván Márquez

I-O in 2L NSCLC & Clinical Cases 

Dra. Clarissa Mathias

Clinical Case Presentation - 2L RCC 

Dr. Enrique Grande

Renal Cell Carcinoma Landscape in Latin America 

Dr. Jose Zarbá

Biomarkers Evolution 

Dr Reinhard Buettner

Practical issues 3: Safety Management in I-O 

Dr. Enrique Grande

Current perspectives of Immuno-Oncology in Melanoma

Dr. Sanjiv Agarwala

Practical issues 1: Patient Selection

Dr. Enrique Grande

Clinical Case 2: Metastatic Melanoma – Combinations 

Dr. Sanjiv Agarwala

Evolution and current perspectives of Immuno-Oncology in 2L RCC

Dr. Enrique Grande

Innovative biomarkers and immune profiling, PD-L1 and other protein immunohistochemistry 

Dr Reinhard Buettner

Oncology pipeline: Biomarker / Translational clinical focused

Dra. Virginia Burns

Immuno-Oncology State of the Art and the Future: Cancer Neoantigens The Next Frontier of Combinational Approaches I-O Agents

Dr. Sergio Quezada.